The dipeptidyl peptidase-4 inhibitor Saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patients

BACKGROUND: Type 2 diabetes (T2D) is associated with reduction and dysfunction of circulating pro-angiogenic cells (PACs). DPP-4 inhibitors, a class of oral agents for T2D, might possess pleiotropic vasculoprotective activities. Herein, we tested whether DPP-4 inhibition with Saxagliptin affects the...

Descripción completa

Detalles Bibliográficos
Autores principales: Poncina, Nicol, Albiero, Mattia, Menegazzo, Lisa, Cappellari, Roberta, Avogaro, Angelo, Fadini, Gian Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033689/
https://www.ncbi.nlm.nih.gov/pubmed/24886621
http://dx.doi.org/10.1186/1475-2840-13-92

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033689/
https://www.ncbi.nlm.nih.gov/pubmed/24886621
http://dx.doi.org/10.1186/1475-2840-13-92

Ejemplares similares